Michael M Kaminski

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Extracellular Matrix

Polycystic Kidney Disease

Top Venues

Science advances

EMBO molecular medicine

Nature nanotechnology

Development (Cambridge, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Robert Greensmith, Isadora T Lape, Cristian V Riella, Alexander J Schubert, Jakob J Metzger, Anand S Dighe, Xiao Tan, Bernhard Hemmer, Josefine Rau, Sarah Wendlinger, Nora Diederich, Anja Schütz, Leonardo V Riella, Michael M Kaminski
CRISPR-enabled point-of-care genotyping for APOL1 genetic risk assessment. EMBO molecular medicine (2024)
Katherine Ilia, Nika Shakiba, Trevor Bingham, Ross D Jones, Michael M Kaminski, Eliezer Aravera, Simone Bruno, Sebastian Palacios, Ron Weiss, James J Collins, Domitilla Del Vecchio, Thorsten M Schlaeger
Synthetic genetic circuits to uncover the OCT4 trajectories of successful reprogramming of human fibroblasts. Science advances 9 (48) (2023)
Marta Broto, Michael M Kaminski, Christopher Adrianus, Nayoung Kim, Robert Greensmith, Schan Dissanayake-Perera, Alexander J Schubert, Xiao Tan, Hyemin Kim, Anand S Dighe, James J Collins, Molly M Stevens
Nanozyme-catalysed CRISPR assay for preamplification-free detection of non-coding RNAs. Nature nanotechnology 17 (10) (2022)
Thomas Naert, Özgün Çiçek, Paulina Ogar, Max Bürgi, Nikko-Ideen Shaidani, Michael M Kaminski, Yuxiao Xu, Kelli Grand, Marko Vujanovic, Daniel Prata, Friedhelm Hildebrandt, Thomas Brox, Olaf Ronneberger, Fabian F Voigt, Fritjof Helmchen, Johannes Loffing, Marko E Horb, Helen Rankin Willsey, Soeren Sten Lienkamp
Deep learning is widely applicable to phenotyping embryonic development and disease. Development (Cambridge, England) 148 (21) (2021)